|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
|---|---|
| Collaborator: |
Medizinisch-wissenschaftlicher Fonds des Bürgermeisters der Stadt Wien, that is, Scientific Fund of the Major of the City of Vienna |
| Information provided by: | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
| ClinicalTrials.gov Identifier: | NCT01165801 |
Purpose
The purpose of this study was to find out if in patients with non-exudative age-related macular degeneration (AMD), randomly assigned to cataract surgery, any AMD size progression or progression to exudative AMD could be detected 6 months after surgery.
| Condition | Intervention | Phase |
|---|---|---|
|
Age-Related Macular Degeneration |
Procedure: Cataract Surgery |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Bio-equivalence Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Size Progression of Non-Exudative Age-Related Macular Degeneration After Cataract Surgery |
| Enrollment: | 54 |
| Study Start Date: | January 2002 |
| Study Completion Date: | July 2010 |
| Primary Completion Date: | September 2007 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: Control Group (CO)
Fifty-four patients with cataract and non-exudative age-related macular degeneration (AMD) were randomized into an early surgery group (ES=28) with immediate cataract surgery and a control group (CO=26) where surgery was performed after six months.
|
Procedure: Cataract Surgery
Fifty-four patients with cataract and non-exudative age-related macular degeneration (AMD) were randomized into an early surgery group (ES=28) with immediate cataract surgery and a control group (CO=26) where surgery was performed after six months.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Austria | |
| The Rudolph Foundation Hospital, Dept. of Ophthalmology | |
| Vienna, Austria, 1030 | |
More Information
| ClinicalTrials.gov Identifier: | NCT01165801 History of Changes |
| Other Study ID Numbers: | EKAM-1-2061 |
| Study First Received: | July 17, 2010 |
| Last Updated: | July 19, 2010 |
| Health Authority: | Austria: Ethikkommission |
|
AMD Cataract surgery Size of AMD Influence of cataract surgery on AMD Size |
|
Macular Degeneration Cataract Geographic Atrophy Retinal Degeneration |
Retinal Diseases Eye Diseases Lens Diseases |